Wujian Mao

596 total citations
26 papers, 360 citations indexed

About

Wujian Mao is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Surgery. According to data from OpenAlex, Wujian Mao has authored 26 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 8 papers in Surgery. Recurrent topics in Wujian Mao's work include Medical Imaging Techniques and Applications (12 papers), Radiomics and Machine Learning in Medical Imaging (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Wujian Mao is often cited by papers focused on Medical Imaging Techniques and Applications (12 papers), Radiomics and Machine Learning in Medical Imaging (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Wujian Mao collaborates with scholars based in China and United States. Wujian Mao's co-authors include Hui Tan, Haojun Yu, Hongcheng Shi, Pengcheng Hu, Hongyan Yin, Xiuli Sui, Lin Qiu, Hongcheng Shi, Yiqiu Zhang and Shuguang Chen and has published in prestigious journals such as American Journal of Roentgenology, European Journal of Nuclear Medicine and Molecular Imaging and European Radiology.

In The Last Decade

Wujian Mao

26 papers receiving 358 citations

Peers

Wujian Mao
Diem Vuong Switzerland
Andrew Mallia United Kingdom
T Beyer Germany
Bradley G. Ackerson United States
Simon Duke United Kingdom
Wujian Mao
Citations per year, relative to Wujian Mao Wujian Mao (= 1×) peers Urban Simončič

Countries citing papers authored by Wujian Mao

Since Specialization
Citations

This map shows the geographic impact of Wujian Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wujian Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wujian Mao more than expected).

Fields of papers citing papers by Wujian Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wujian Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wujian Mao. The network helps show where Wujian Mao may publish in the future.

Co-authorship network of co-authors of Wujian Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Wujian Mao. A scholar is included among the top collaborators of Wujian Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wujian Mao. Wujian Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Hongyan, Guobing Liu, Wujian Mao, et al.. (2024). Parametric net influx rate imaging of 68Ga-DOTATATE in patients with neuroendocrine tumors: assessment of lesion detectability. Annals of Nuclear Medicine. 38(7). 483–492. 1 indexed citations
2.
Zheng, Zhe, Wujian Mao, Haojun Yu, et al.. (2024). Exploration the feasibility and additional value of [18F]FDG/[68Ga]Ga-FAPI-04 dual-low-activity-tracer one-stop total-body PET imaging at 34 min post-injection of [68Ga]Ga-FAPI-04. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 638–647. 3 indexed citations
3.
Liu, Guobing, Wujian Mao, Haojun Yu, et al.. (2023). One-stop [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 total-body PET/CT examination with dual-low activity: a feasibility study. European Journal of Nuclear Medicine and Molecular Imaging. 50(8). 2271–2281. 22 indexed citations
5.
Pang, Lifang, Wujian Mao, Yiqiu Zhang, et al.. (2023). Comparison of 18F-FDG PET/MR and PET/CT for pretreatment TNM staging of hilar cholangiocarcinoma. Abdominal Radiology. 48(8). 2537–2546. 2 indexed citations
6.
Zheng, Zhe, Haojun Yu, Wujian Mao, et al.. (2023). The earliest optimal timing for total-body 68Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study. European Radiology. 34(7). 4550–4560. 9 indexed citations
7.
Yin, Hongyan, Guobing Liu, Yan Hu, et al.. (2023). Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of 68Ga-DOTATATE in Normal Organs. Contrast Media & Molecular Imaging. 2023. 1–11. 7 indexed citations
8.
Tan, Hui, Wujian Mao, Haojun Yu, et al.. (2023). Ultralow-dose [18F]FDG PET/CT imaging: demonstration of feasibility in dynamic and static images. European Radiology. 33(7). 5017–5027. 14 indexed citations
9.
Zhang, He, Haojun Yu, Hui Tan, et al.. (2022). An initial study on the comparison of diagnostic performance of 18F-FDG PET/MR and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer: Focus on pleural invasion. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 42(1). 16–23. 8 indexed citations
10.
Yin, Hongyan, Wujian Mao, Hui Tan, et al.. (2021). Role of 18F-FDG PET/CT imaging in cardiac and pericardial masses. Journal of Nuclear Cardiology. 29(3). 1293–1303. 12 indexed citations
11.
Tan, Hui, Xiuli Sui, Wujian Mao, et al.. (2021). Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience. European Journal of Nuclear Medicine and Molecular Imaging. 49(3). 1002–1011. 32 indexed citations
12.
Lv, Jing, Hongyan Yin, Wujian Mao, & Hongcheng Shi. (2021). Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation. Abdominal Radiology. 46(6). 2490–2497. 7 indexed citations
13.
Tan, Hui, Mieradilijiang Abudupataer, Lin Qiu, et al.. (2020). 99m Tc‐labeled Duramycin for detecting and monitoring cardiomyocyte death and assessing atorvastatin cardioprotection in acute myocardial infarction. Chemical Biology & Drug Design. 97(2). 210–220. 2 indexed citations
14.
Mao, Wujian, Jun Zhou, Lin Qiu, et al.. (2020). The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases. Abdominal Radiology. 45(4). 1075–1081. 13 indexed citations
15.
Tan, Hui, Xiuli Sui, Hongyan Yin, et al.. (2020). Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 1966–1975. 85 indexed citations
16.
Qiu, Lin, Wujian Mao, Hongyan Yin, et al.. (2019). Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels–Alder Reaction and Key Factors in the Pretargeted Synthetic Design. Contrast Media & Molecular Imaging. 2019. 1–12. 8 indexed citations
17.
Zhou, Jun, Pengcheng Hu, Hui Tan, et al.. (2019). Treatment of Hepatocellular Carcinoma by Intratumoral Injection of 125I-AA98 mAb and Its Efficacy Assessments by Molecular Imaging. Frontiers in Bioengineering and Biotechnology. 7. 319–319. 8 indexed citations
18.
Qiu, Lin, Hui Tan, Qingyu Lin, et al.. (2019). A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry. Molecular Imaging and Biology. 22(4). 842–853. 19 indexed citations
19.
Zhang, He, Jie Xiao, Jun Zhou, et al.. (2019). 18F-PBR06 PET/CT imaging for evaluating atherosclerotic plaques linked to macrophage infiltration. Nuclear Medicine Communications. 40(4). 370–376. 8 indexed citations
20.
Mao, Wujian, Jun Zhou, He Zhang, et al.. (2018). Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases. Abdominal Radiology. 44(6). 2059–2066. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026